{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:14:40Z","timestamp":1788383680909,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["XKP2019007"],"award-info":[{"award-number":["XKP2019007"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["XK2019002"],"award-info":[{"award-number":["XK2019002"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074082"],"award-info":[{"award-number":["82074082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673845"],"award-info":[{"award-number":["81673845"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key areas of Guangdong Province","doi-asserted-by":"publisher","award":["2020B1111100010"],"award-info":[{"award-number":["2020B1111100010"]}],"id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515011490"],"award-info":[{"award-number":["2021A1515011490"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515010819"],"award-info":[{"award-number":["2019A1515010819"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.phymed.2021.153550","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T10:29:58Z","timestamp":1616063398000},"page":"153550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats"],"prefix":"10.1016","volume":"85","author":[{"given":"Qiao-Ping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Xing","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Fang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ren","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2021.153550_bib0001","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jcb.26174","article-title":"Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus","volume":"119","author":"Akash","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.phymed.2021.153550_bib0002","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/cvr\/cvx106","article-title":"The molecular mechanisms of obesity paradox","volume":"113","author":"Antonopoulos","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phymed.2021.153550_bib0003","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.phymed.2021.153550_bib0004","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2021.153550_bib0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ecl.2008.06.007","article-title":"Obesity and free fatty acids","volume":"37","author":"Boden","year":"2008","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.phymed.2021.153550_bib0006","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2021.153550_bib0007","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.phymed.2021.153550_bib0008","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.1021\/acs.jmedchem.6b00866","volume":"59","author":"Cameron","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phymed.2021.153550_bib0009","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jep.2013.07.025","article-title":"Berberine metabolites exhibit triglyceride-lowering effects via activation of AMP-activated protein kinase in Hep G2 cells","volume":"149","author":"Cao","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2021.153550_bib0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","article-title":"AMPK signalling in health and disease","volume":"45","author":"Carling","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.phymed.2021.153550_bib0011","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s10495-014-0977-0","article-title":"Berberine reduces ischemia\/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats","volume":"19","author":"Chen","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.phymed.2021.153550_bib0012","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1476-5381.1996.tb15431.x","article-title":"Mechanical and electrophysiological effects of 8-oxoberberine (JKL1073A) on atrial tissue","volume":"118","author":"Chi","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153550_bib0013","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00125-011-2407-y","article-title":"Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle","volume":"55","author":"Chopra","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.phymed.2021.153550_bib0014","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/nu10091153","article-title":"Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence","volume":"10","author":"Cicero","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.phymed.2021.153550_bib0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2021.153550_bib0016","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17460441.2018.1410135","article-title":"Non-alcoholic fatty liver disease (NAFLD) models in drug discovery","volume":"13","author":"Cole","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.phymed.2021.153550_bib0017","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cmet.2019.06.017","article-title":"Generation of human fatty livers using custom-engineered induced pluripotent stem cells with modifiable SIRT1 metabolism","volume":"30","author":"Collin de l'Hortet","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2021.153550_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2013.09.019","article-title":"Obesity and liver disease: the epidemic of the twenty-first century","volume":"18","author":"Corey","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.phymed.2021.153550_bib0019","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","article-title":"AMPK as a therapeutic target for treating metabolic diseases","volume":"28","author":"Day","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.phymed.2021.153550_bib0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/cells8080795","article-title":"Mitochondrial uncoupling: a key controller of biological processes in physiology and diseases","volume":"8","author":"Demine","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phymed.2021.153550_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111312","article-title":"Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K\/Akt and Nrf2 signaling pathways","volume":"137","author":"Dou","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2021.153550_bib0022","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jcmgh.2019.02.001","article-title":"Macronutrients and the adipose-liver axis in obesity and fatty liver","volume":"7","author":"Duwaerts","year":"2019","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2021.153550_bib0023","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol."},{"key":"10.1016\/j.phymed.2021.153550_bib0024","doi-asserted-by":"crossref","first-page":"e13049","DOI":"10.1111\/jfbc.13049","article-title":"Berberine chloride ameliorated PI3K\/Akt-p\/SIRT-1\/PTEN signaling pathway in insulin resistance syndrome induced in rats","volume":"43","author":"El-Zeftawy","year":"2019","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.phymed.2021.153550_bib0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-3-319-48382-5_8","article-title":"What is lipotoxicity?","volume":"960","author":"Engin","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phymed.2021.153550_bib0026","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2021.153550_bib0027","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.7150\/thno.30787","article-title":"Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.phymed.2021.153550_bib0028","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein-ligand docking and virtual drug screening with the autodock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.phymed.2021.153550_bib0029","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2021.153550_bib0030","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/dom.13592","article-title":"Of mice and men: is there a future for metformin in the treatment of hepatic steatosis?","volume":"21","author":"Green","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phymed.2021.153550_bib0031","doi-asserted-by":"crossref","first-page":"22612","DOI":"10.1038\/srep22612","article-title":"Berberine ameliorates hepatic steatosis and suppresses liver and adipose tissue inflammation in mice with diet-induced obesity","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2021.153550_bib0032","first-page":"3322","article-title":"Berberine is a potential therapeutic agent for metabolic syndrome via brown adipose tissue activation and metabolism regulation","volume":"10","author":"Hu","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.phymed.2021.153550_bib0033","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3390\/ijms18071408","article-title":"Identification of direct activator of adenosine monophosphate-activated protein kinase (AMPK) by structure-based virtual screening and molecular docking approach","volume":"18","author":"Huang","year":"2017","journal-title":"Int. J. Mol."},{"key":"10.1016\/j.phymed.2021.153550_bib0034","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1038\/emm.2016.16","article-title":"AMPK activators: mechanisms of action and physiological activities","volume":"48","author":"Kim","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phymed.2021.153550_bib0035","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrd.2016.75","article-title":"Targeting adipose tissue in the treatment of obesity-associated diabetes","volume":"15","author":"Kusminski","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2021.153550_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104603","article-title":"Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-kappaB pathway","volume":"152","author":"Li","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2021.153550_bib0037","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.phymed.2018.09.228","article-title":"Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo","volume":"52","author":"Li","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2021.153550_bib0038","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.compbiolchem.2019.02.007","article-title":"Identification of potential AMPK activator by pharmacophore modeling, molecular docking and QSAR study","volume":"79","author":"Li","year":"2019","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.phymed.2021.153550_bib0039","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1479-5876-9-62","article-title":"Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes","volume":"9","author":"Li","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phymed.2021.153550_bib0040","doi-asserted-by":"crossref","first-page":"45304","DOI":"10.1074\/jbc.C400186200","article-title":"Protein kinase C theta inhibits insulin signaling by phosphorylating IRS1 at Ser (1101)","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2021.153550_bib0041","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1038\/s41598-017-05996-5","article-title":"Transformation of patchouli alcohol to beta-patchoulene by gastric juice: beta-patchoulene is more effective in preventing ethanol-induced gastric injury","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2021.153550_bib0042","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1124\/dmd.110.033936","article-title":"Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats","volume":"38","author":"Liu","year":"2010","journal-title":"Drug Metab. Disposition"},{"key":"10.1016\/j.phymed.2021.153550_bib0043","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10753-010-9276-2","article-title":"Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes","volume":"34","author":"Lou","year":"2011","journal-title":"Inflammation"},{"key":"10.1016\/j.phymed.2021.153550_bib0044","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2016.11.010","article-title":"Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation","volume":"440","author":"Mancini","year":"2017","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.phymed.2021.153550_bib0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2021.153550_bib0046","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-2006-958107","article-title":"Lipoxygenase inhibition and antioxidant properties of protoberberine and aporphine alkaloids isolated from Mahonia aquifolium","volume":"61","author":"Mis\u00edk","year":"1995","journal-title":"Planta Med."},{"key":"10.1016\/j.phymed.2021.153550_bib0047","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1210\/me.2009-0474","article-title":"AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation","volume":"24","author":"Ning","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.phymed.2021.153550_bib0048","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/905749","article-title":"Application of berberine on treating type 2 diabetes mellitus","author":"Pang","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.phymed.2021.153550_bib0049","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.livres.2018.02.002","article-title":"The role of adipose tissue in fatty liver diseases","volume":"2","author":"Parker","year":"2018","journal-title":"Liver Res."},{"key":"10.1016\/j.phymed.2021.153550_bib0050","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/BST0320803","article-title":"Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?","volume":"32","author":"Patel","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.phymed.2021.153550_bib0051","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phymed.2021.153550_bib0052","article-title":"Management of non-alcoholic fatty liver disease","volume":"372","author":"Petroni","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2021.153550_bib0053","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bbrc.2016.03.019","article-title":"Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress","volume":"472","author":"Qiang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2021.153550_bib0054","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/imm.13002","article-title":"Properties and functions of adipose tissue macrophages in obesity","volume":"155","author":"Russo","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.phymed.2021.153550_bib0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2021.153550_bib0056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179777","article-title":"Differential roles of 3-hydroxyflavone and 7-hydroxyflavone against nicotine-induced oxidative stress in rat renal proximal tubule cells","volume":"12","author":"Sengupta","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2021.153550_bib0057","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2478\/v10045-009-0046-9","article-title":"Fungal spore germination inhibition by alkaloids dehydrocorydalmine and oxyberberine","volume":"49","author":"Singh","year":"2009","journal-title":"J. Plant Prot. Res."},{"key":"10.1016\/j.phymed.2021.153550_bib0058","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/13880209.2015.1073334","article-title":"Cytotoxicity of alkaloids isolated from Argemone Mexicana on SW480 human colon cancer cell line","volume":"54","author":"Singh","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.phymed.2021.153550_bib0059","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fphar.2016.00362","article-title":"Rhizoma Coptidis: a potential cardiovascular protective agent","volume":"7","author":"Tan","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153550_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105802","article-title":"Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese cortex, exerts anti-inflammatory effect via dual modulation of NF-kappaB and MAPK signaling pathways","volume":"75","author":"Tan","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2021.153550_bib0061","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","article-title":"Unraveling the regulation of hepatic metabolism by insulin","volume":"28","author":"Titchenell","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.phymed.2021.153550_bib0062","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tem.2015.03.002","article-title":"The brown fat secretome: metabolic functions beyond thermogenesis","volume":"26","author":"Wang","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.phymed.2021.153550_bib0063","doi-asserted-by":"crossref","first-page":"10135","DOI":"10.18632\/oncotarget.20807","article-title":"Metformin and berberine, two versatile drugs in treatment of common metabolic diseases","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2021.153550_bib0064","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/13880209.2019.1577466","article-title":"Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology","volume":"57","author":"Wang","year":"2019","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.phymed.2021.153550_bib0065","first-page":"E1","article-title":"AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes","volume":"277","author":"Winder","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.phymed.2021.153550_bib0066","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/1389200211209050558","article-title":"Pharmacokinetics-pharmacology disconnection of herbal medicines and its potential solutions with cellular pharmacokinetic-pharmacodynamic strategy","volume":"13","author":"Zhang","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.phymed.2021.153550_bib0067","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11596-019-1997-3","article-title":"Berberine ameliorates high-fat diet-induced non-alcoholic fatty liver disease in rats via activation of SIRT3\/AMPK\/ACC pathway","volume":"39","author":"Zhang","year":"2019","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.phymed.2021.153550_bib0068","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1039\/C7FO02048A","article-title":"Octahydrocurcumin, a final hydrogenated metabolite of curcumin, possesses superior anti-tumor activity through induction of cellular apoptosis","volume":"9","author":"Zhang","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.phymed.2021.153550_bib0069","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1038\/ncomms6493","article-title":"Berberine activates thermogenesis in white and brown adipose tissue","volume":"5","author":"Zhang","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2021.153550_bib0070","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3389\/fphar.2018.01181","article-title":"Curcumin's metabolites, tetrahydrocurcumin and octahydrocurcumin, possess superior anti-inflammatory effects in vivo through suppression of TAK1-NF-kappaB pathway","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153550_bib0071","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3390\/molecules21101336","article-title":"The potential mechanisms of berberine in the treatment of nonalcoholic fatty liver disease","volume":"21","author":"Zhu","year":"2016","journal-title":"Molecules"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321000921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321000921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:30:28Z","timestamp":1778776228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711321000921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":71,"alternative-id":["S0944711321000921"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153550","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153550"}}